In what at first may appear to be an oversight, there isn’t a single mention of intellectual property law on the website bio of Stephanie Parker, the lawyer who led the team that achieved last week’s record-breaking $2.54 billion patent infringement verdict for client Idenix Pharmaceuticals.
But it was no blunder by the marketing team at Jones Day, where Parker is a partner. The co-head of the firm’s business and tort litigation group has dozens upon dozens of trials under her belt. But when it comes to intellectual property law, the epic patent battle between her Merck-subsidiary client and Gilead Sciences was Parker’s first attempt at an intellectual property case.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
